ABBV-951
Showing 76 - 100 of 121
Rheumatoid Arthritis (RA) Trial in Worldwide (ABBV-3373, Placebo for ABBV-3373, Adalimumab)
Advanced Renal Cell Carcinoma Trial in Worldwide (Tivozanib, Sorafenib)
Completed
- Advanced Renal Cell Carcinoma
-
Los Angeles, California
- +74 more
Sep 11, 2020
Progressive Supranuclear Palsy (PSP) Trial in Worldwide (ABBV-8E12, Placebo solution for IV infusion on Day 15)
Terminated
- Progressive Supranuclear Palsy (PSP)
- ABBV-8E12
- Placebo solution for IV infusion on Day 15
-
Birmingham, Alabama
- +41 more
Feb 1, 2021
Carcinoma, Renal Cell Trial in India, Russian Federation, Ukraine (Tivozanib (AV-951), Placebo comparator)
Completed
- Carcinoma, Renal Cell
- Tivozanib (AV-951)
- Placebo comparator
-
Vellore, Tamil Nadu, India
- +25 more
Aug 17, 2020
Crohn Disease Trial in Worldwide (Risankizumab 600 mg IV, Risankizumab 180 mg SC)
Completed
- Crohn Disease
- Risankizumab 600 mg IV
- Risankizumab 180 mg SC
-
Chevy Chase, Maryland
- +27 more
Apr 9, 2020
Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)
Multiple Myeloma Trial in Worldwide (Eftozanermin alfa, Bortezomib, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Eftozanermin alfa
- +2 more
-
Atlanta, Georgia
- +18 more
Oct 12, 2022
Solid Tumors Trial in Worldwide (Tivozanib + paclitaxel, Tivozanib + temsirolimus, Tivozanib)
Terminated
- Solid Tumors
- Tivozanib + paclitaxel
- +5 more
-
Scottsdale, Arizona
- +48 more
Aug 17, 2020
Primary Tauopathy Corticobasal Degeneration Syndrome (CBD) Trial (ABBV-8E12)
No longer available
- Primary Tauopathy Corticobasal Degeneration Syndrome (CBD)
- (no location specified)
Aug 16, 2019
Advanced Renal Cell Carcinoma Trial in Worldwide (tivozanib (AV-951), Sorafenib)
Completed
- Advanced Renal Cell Carcinoma
- tivozanib (AV-951)
- Sorafenib
-
Los Angeles, California
- +85 more
Oct 7, 2019
Arthritis, Psoriatic Trial (risankizumab, for risankizumab)
Completed
- Arthritis, Psoriatic
- risankizumab
- placebo for risankizumab
- (no location specified)
May 28, 2019